Soligenix SNGX
NASDAQ SNGX
$0.40 +0.02 (+5.50%)
At close: Aug 21, 2026 · 4:00 PM EDT

Soligenix (SNGX) Free Cash Flow (2010 - 2026)

Soligenix's (SNGX) quarterly Free Cash Flow came in at -$2.4 million in Q1 2026, down 27.65% YoY from -$3.3 million in Q1 2025, and up 14.17% on a QoQ basis from -$2.7 million in Q4 2025.

Soligenix (SNGX) Free Cash Flow (2010 - 2026) Analysis & Trends

Soligenix (SNGX) has 17 years of Free Cash Flow data on file, last reported at -$2.4 million in Q1 2026.

  • Quarterly Free Cash Flow fell 27.65% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.8 million (down 21.01% YoY) and the FY2025 annual result came in at -$10.3 million, down 22.24% from the prior year.
  • Free Cash Flow climbed to -$2.4 million in Q1 2026, from -$2.7 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$1.3 million in Q1 2024 to a low of -$3.6 million in Q4 2022.
  • A 5-year average of -$2.5 million and a median of -$2.5 million in 2022 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 52.59% — and 2023, when it soared 49.6%.
  • Tracing SNGX's Free Cash Flow over 5 years: stood at -$3.6 million in 2022, then surged by 49.6% to -$1.8 million in 2023, then slipped by 22.13% to -$2.2 million in 2024, then slipped by 23.03% to -$2.7 million in 2025, then grew by 14.17% to -$2.4 million in 2026.
  • The last three Free Cash Flow figures came in at -$2.4 million (Q1 2026), -$2.7 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -563.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 437.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 292.04 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 433.84 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -95.09 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 477.44 Mn
10 Soligenix 6.45 Mn 6.45 Mn - -1.71 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.71 Mn
Jun 30, 2026 -1.71 Mn
Mar 31, 2026 -2.36 Mn
Mar 31, 2026 -2.36 Mn
Dec 31, 2025 -2.75 Mn
Dec 31, 2025 -2.75 Mn
Sep 30, 2025 -2.93 Mn
Sep 30, 2025 -2.93 Mn
Jun 30, 2025 -2.74 Mn
Jun 30, 2025 -2.74 Mn
Mar 31, 2025 -1.85 Mn
Mar 31, 2025 -1.85 Mn
Dec 31, 2024 -2.23 Mn
Dec 31, 2024 -2.23 Mn
Sep 30, 2024 -2.91 Mn
Sep 30, 2024 -2.91 Mn
Jun 30, 2024 -1.92 Mn
Jun 30, 2024 -1.92 Mn
Mar 31, 2024 -1.34 Mn
Mar 31, 2024 -1.34 Mn